Globe Life Inc. (NYSE:GL – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ten analysts that are covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $171.3333.
Several equities research analysts recently weighed in on GL shares. Evercore set a $157.00 price objective on Globe Life in a report on Wednesday, February 18th. TD Cowen reiterated a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Morgan Stanley reiterated an “overweight” rating and issued a $176.00 target price on shares of Globe Life in a research note on Monday, December 15th. JPMorgan Chase & Co. upped their price target on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Finally, Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, February 13th.
Read Our Latest Report on Globe Life
More Globe Life News
- Positive Sentiment: Board raised the quarterly dividend to $0.33 (22.2% increase) and announced two new board members — supports income-focused investors and signals confidence in cash flow. GLOBE LIFE INC. DECLARES DIVIDEND AND ANNOUNCES APPOINTMENT OF TWO NEW BOARD MEMBERS
- Positive Sentiment: Wells Fargo published a positive price-forecast note on Globe Life, which can attract buyers and lend near-term support to the share price. Wells Fargo & Company Issues Positive Forecast for Globe Life (NYSE:GL) Stock Price
- Neutral Sentiment: Globe Life Field booked for an Eagles concert, which forced a local high school to reschedule prom — shows strong event demand and venue utilization but has minimal direct impact on insurance operations. Eagles concert at Globe Life Field moves Texas high school’s prom night date How an Eagles concert at Globe Life Field bumped a North Texas high school prom
- Neutral Sentiment: GL was included in a Zacks piece highlighting high-ROE stocks as resilient plays; such coverage may raise investor interest but is not a company-specific catalyst. Buy 5 Stocks With High ROE as Markets Dance Whimsically to the AI Tune
- Negative Sentiment: CEO James Matthew Darden sold 9,527 shares (~15% reduction in his reported ownership), a sizable insider sale that can spook some investors. SEC Form 4 – Darden sale
- Negative Sentiment: EVP Robert Edward Hensley sold 712 shares (~7.7% reduction in his holding), another insider sale that adds to selling pressure signals. SEC Form 4 – Hensley sale
- Negative Sentiment: TipRanks flagged Globe Life’s rising allocation to alternative assets as increasing volatility, capital strain and liquidity risk — a potential medium-term headwind for valuation if realized. Globe Life’s Growing Alternative Asset Bets Raise Volatility, Capital Strain and Liquidity Risk
Insider Buying and Selling at Globe Life
In other news, EVP Robert Edward Hensley sold 712 shares of the company’s stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $142.59, for a total value of $101,524.08. Following the sale, the executive vice president directly owned 8,580 shares of the company’s stock, valued at $1,223,422.20. This represents a 7.66% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CMO Jennifer Allison Haworth sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $143.14, for a total value of $1,431,400.00. Following the completion of the sale, the chief marketing officer owned 17,479 shares in the company, valued at $2,501,944.06. The trade was a 36.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 73,868 shares of company stock worth $10,700,437 over the last ninety days. 1.51% of the stock is owned by company insiders.
Institutional Trading of Globe Life
Institutional investors have recently added to or reduced their stakes in the business. Norges Bank bought a new stake in Globe Life in the 2nd quarter worth about $157,722,000. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Globe Life by 34,786.0% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock worth $123,345,000 after buying an additional 879,391 shares during the last quarter. AQR Capital Management LLC boosted its stake in shares of Globe Life by 98.6% during the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after acquiring an additional 696,548 shares during the last quarter. Balyasny Asset Management L.P. purchased a new stake in Globe Life in the third quarter worth about $80,925,000. Finally, Westfield Capital Management Co. LP bought a new stake in Globe Life during the 3rd quarter worth approximately $61,569,000. 81.61% of the stock is currently owned by hedge funds and other institutional investors.
Globe Life Price Performance
Globe Life stock opened at $145.32 on Friday. Globe Life has a 12 month low of $109.38 and a 12 month high of $152.71. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41. The business’s 50 day simple moving average is $141.88 and its 200 day simple moving average is $138.72. The company has a market cap of $11.43 billion, a price-to-earnings ratio of 10.32 and a beta of 0.47.
Globe Life (NYSE:GL – Get Free Report) last released its earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The firm had revenue of $1.52 billion during the quarter, compared to analysts’ expectations of $1.53 billion. Globe Life had a return on equity of 21.75% and a net margin of 19.37%.During the same period in the prior year, the business earned $3.14 earnings per share. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Sell-side analysts forecast that Globe Life will post 13.87 EPS for the current year.
Globe Life Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be issued a dividend of $0.33 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $1.32 annualized dividend and a dividend yield of 0.9%. This is an increase from Globe Life’s previous quarterly dividend of $0.27. Globe Life’s payout ratio is 7.67%.
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Read More
- Five stocks we like better than Globe Life
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
